Metformin in aging and aging-related diseases: clinical applications and relevant mechanisms

Theranostics. 2022 Mar 6;12(6):2722-2740. doi: 10.7150/thno.71360. eCollection 2022.


Aging is a natural process, which plays a critical role in the pathogenesis of a variety of diseases, i.e., aging-related diseases, such as diabetes, osteoarthritis, Alzheimer disease, cardiovascular diseases, cancers, obesity and other metabolic abnormalities. Metformin, the most widely used antidiabetic drug, has been reported to delay aging and display protective effect on attenuating progression of various aging-related diseases by impacting key hallmark events of aging, including dysregulated nutrient sensing, loss of proteostasis, mitochondrial dysfunction, altered intercellular communication, telomere attrition, genomic instability, epigenetic alterations, stem cell exhaustion and cellular senescence. In this review, we provide updated information and knowledge on applications of metformin in prevention and treatment of aging and aging-related diseases. We focus our discussions on the roles and underlying mechanisms of metformin in modulating aging and treating aging-related diseases.

Keywords: Metformin; aging; aging-related diseases; clinical application; molecular mechanism..

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging / pathology
  • Cellular Senescence
  • Genomic Instability
  • Humans
  • Metformin* / pharmacology
  • Metformin* / therapeutic use
  • Telomere


  • Metformin